GCIA
ENTL

Gabelli & Co Investment Advisers’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio ENTL Stock Details ENTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-42,901
Closed -$1.05M – 181
2017
Q4 		$1.05M Buy
+42,901
New +$825K 0.14% 80

Gabelli & Co Investment Advisers's ENTL Position: Q1 2018 in Review

Gabelli & Co Investment Advisers sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 42,901 shares — an estimated $1.05M sold.

Gabelli & Co Investment Advisers first reported a position in ENTL in Q4 2017 and held it in 1 quarter. The position peaked at $1.05M in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

  • Gabelli & Co Investment Advisers reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 42,901 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $1.05M.
  • Gabelli & Co Investment Advisers first reported a position in Entellus Medical, Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • Gabelli & Co Investment Advisers's Entellus Medical, Inc. Common Stock position peaked at $1.05M in Q4 2017.
  • 0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2018, filed 9 May 2018.